Biotech ETF Rises 17% in a Month Without NVIDIA
A biotech ETF posts a 17% gain in the trailing month even as NVIDIA weakens, underscoring a sector rotation that chal...
Why Avoid Individual Stocks
Why Avoid Individual Stocks highlights the risks of single-stock bets and why broad index funds offer steadier long-term growth for most investors.
22,058 articles
ZachXBT Turns Unwanted Meme Coins Into Relief Funds
Crypto investigator ZachXBT redirected about $41,000 in unsolicited meme-coin inflows into earthquake relief for Vene...
Hynix Memory Chips IPO Tests AI Stock Market Appetite
SK Hynix is lining up a U.S. listing on Nasdaq, aiming to raise about $28 billion as memory chips ride AI demand and ...
Taylor Swift Wins Dismissal: A Creator Finance Lesson
A high-profile ruling on copyright claims offers a blueprint for managing legal risk and protecting earnings. This ar...
Today’s Dividend Yield Least Isn’t the KPI Investors Need
As markets shift, today’s dividend yield least takes center stage in debates on income strategies. Growth and payout ...
Is Rivian Worth Half Ford? Markets Weigh the Gap Today
Rivian remains valued far below Ford despite big hype around electric-vehicle startups. With Rivian’s deliveries risi...
Broadcom Spikes Expanded Apple Deal, Lifts Stock Broadly
Broadcom climbs about 5% to around $390 after Apple expands its multiyear chip deal. Intel and AMD drift lower as inv...
Widow’s First Year Filing Could Raise Medicare Premiums
A widow’s first year filing solo can push Medicare premiums higher through IRMAA, potentially adding hundreds of doll...
The $23,000 Limit, $4,945 Reality: Workers Leave $18K Behind
A fresh look at retirement saving shows the typical worker saves far less than the official 401(k) limit, creating a ...
At $32, Dream Finders-Beazer Risk Doubles in Rating Drama
Dream Finders has offered cash to acquire Beazer at roughly $32 per share, elevating the stakes for both companies. T...
Genius Deadline Puts Stablecoin Issuers on the Clock
As July 18, 2026 approaches, the GENIUS Act deadline accelerates rulemaking for stablecoin issuers. Regulators from T...
Abbott’s Everyday Products Dominate Danaher’s Biotech Gear Market
Abbott Laboratories posted a stronger quarter driven by consumer-facing devices and diagnostics, while Danaher faced ...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status